Concepts of myelin and myelination in neuroradiology.

Until the advent of MR imaging, knowledge of the structure of myelin and the process of myelination were of little importance to the neuroradiologist. Other than some mild changes in the attenuation of white matter, myelination resulted in no significant alterations of CT (1) or sonographic studies. MR studies, on the other hand, have been increasingly used for pediatric brain imaging. MR imaging's greater sensitivity to small changes in the water content of brain tissue, to changes in the binding of free water (revealed by magnetization transfer), and to the extent and anisotropy of water diffusion (revealed by diffusion imaging) has cast new light on this very complex and important molecule. Assessing myelination has become a key component of evaluating the child with delayed development. Moreover, better understanding of the nature of myelin and the effect of its different components on MR imaging parameters may help us to understand and diagnose inborn errors of metabolism better. In this review, I discuss what is known regarding the function and structure of CNS myelin and the effects of the various components of myelin on the signal imparted to the MR image. Summary Abnormalities of myelin can cause a wide variety of disorders of the nervous system. MR imaging is a powerful tool for the study of myelin and its disorders. However, only by understanding the physiologic properties and structure of myelin can we use MR imaging to its fullest capacity for studying patients with myelin disorders. In this review, I have discussed the structure of myelin as it relates to MR imaging of normal myelination and to neurologic disorders resulting from abnormalities of myelin. Thinking of myelin and its disorders in this manner will be critical to using MR imaging techniques optimally to diagnose and study these disorders further.

[1]  M. Dennis,et al.  Developmental neurobiology , 1971, Neurology.

[2]  D. Enzmann,et al.  Using computed tomography of the brain to correlate low white-matter attenuation with early gestational age in neonates. , 1981, Radiology.

[3]  D. Kirschner,et al.  Myelin labeled with mercuric chloride. Asymmetric localization of phosphatidylethanolamine plasmalogen. , 1982, Journal of molecular biology.

[4]  R. Quarles.  Myelin-associated glycoprotein in development and disease. , 1983, Developmental neuroscience.

[5]  P. Braun,et al.  Molecular Organization of Myelin , 1984 .

[6]  A. Campagnoni,et al.  Expression of Myelin Basic Protein Genes in Several Dysmyelinating Mouse Mutants During Early Postnatal Brain Development , 1985, Journal of neurochemistry.

[7]  T. H. Newton,et al.  MRI of normal brain maturation. , 1986, AJNR. American journal of neuroradiology.

[8]  A. J. Kumar,et al.  Adrenoleukodystrophy: correlating MR imaging with CT. , 1987, Radiology.

[9]  C. McArdle,et al.  Developmental features of the neonatal brain: MR imaging. Part I. Gray-white matter differentiation and myelination. , 1987, Radiology.

[10]  B. Trapp.  Distribution of the myelin-associated glycoprotein and P0 protein during myelin compaction in quaking mouse peripheral nerve , 1988, The Journal of cell biology.

[11]  R K Taira,et al.  MR evaluation of early myelination patterns in normal and developmentally delayed infants. , 1988, AJR. American journal of roentgenology.

[12]  R Kikinis,et al.  Developmental stages of human brain: an MR study. , 1988, Journal of computer assisted tomography.

[13]  H I Goldberg,et al.  Multiple sclerosis: serial study of gadolinium-enhanced MR imaging. , 1988, Radiology.

[14]  D. Norman,et al.  Normal maturation of the neonatal and infant brain: MR imaging at 1.5 T. , 1988, Radiology.

[15]  C R Bird,et al.  MR assessment of myelination in infants and children: usefulness of marker sites. , 1989, AJNR. American journal of neuroradiology.

[16]  N. Lundbom,et al.  Relaxometry of brain: Why white matter appears bright in MRI , 1990, Magnetic resonance in medicine.

[17]  Y Tamagawa,et al.  Adult and neonatal human brain: diffusional anisotropy and myelination with diffusion-weighted MR imaging. , 1991, Radiology.

[18]  C. Williams,et al.  Complete deletion of the proteolipid protein gene (PLP) in a family with X-linked Pelizaeus-Merzbacher disease. , 1991, American journal of human genetics.

[19]  Carbon-13 magic angle spinning NMR studies of myelin membranes , 1991 .

[20]  J. Volpe.  Brain development--normal and abnormal. , 1991, Journal of perinatal medicine.

[21]  T. Weimbs,et al.  Proteolipid protein (PLP) of CNS myelin: positions of free, disulfide-bonded, and fatty acid thioester-linked cysteine residues and implications for the membrane topology of PLP. , 1992, Biochemistry.

[22]  R I Grossman,et al.  Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. , 1992, Radiology.

[23]  E. Oldfield,et al.  Carbon‐13 “magic‐angle” sample‐spinning nuclear magnetic resonance studies of human myelin, and model membrane systems , 1993, Magnetic resonance in medicine.

[24]  J. Roder,et al.  Myelination in the absence of myelin-associated glycoprotein , 1994, Nature.

[25]  G. Barker,et al.  Correlation of magnetization transfer ration with clinical disability in multiple sclerosis , 1994, Annals of neurology.

[26]  R M Henkelman,et al.  Relaxivity and magnetization transfer of white matter lipids at MR imaging: importance of cerebrosides and pH. , 1994, Radiology.

[27]  S. Baum,et al.  The Effects of Aspirin on Gastric Prostaglandins , 1994, Annals of Internal Medicine.

[28]  C. P. Morris,et al.  Molecular genetics of metachromatic leukodystrophy , 1994, Journal of inherited metabolic disease.

[29]  T Nakagawa,et al.  Diffusional anisotropy of the human brain assessed with diffusion-weighted MR: relation with normal brain development and aging. , 1994, AJNR. American journal of neuroradiology.

[30]  J. Kucharczyk,et al.  Identification of “Premyelination” by Diffusion‐Weighted MRI , 1995, Journal of computer assisted tomography.

[31]  J. Valk,et al.  Myelin and White Matter , 1995 .

[32]  R I Grossman,et al.  Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. , 1995, Radiology.

[33]  PhD Marjo S. van der Knaap MD,et al.  Magnetic Resonance of Myelin, Myelination, and Myelin Disorders , 1995, Springer Berlin Heidelberg.

[34]  H. Moser,et al.  Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy. , 1995, The Journal of clinical investigation.

[35]  Jumi Lee,et al.  Influence of membrane lipid packing on T2‐weighted magnetic resonance images: Study of relaxation parameters in model membrane systems , 1996, Magnetic resonance in medicine.

[36]  Moses Rodriguez,et al.  Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis , 1996, Brain pathology.

[37]  P. Knapp.  Proteolipid protein: is it more than just a structural component of myelin? , 1996, Developmental neuroscience.

[38]  R. Grossman,et al.  White matter changes associated with deletions of the long arm of chromosome 18 (18q- syndrome): a dysmyelinating disorder? , 1996, AJNR. American journal of neuroradiology.

[39]  B. Weinshenker,et al.  Epidemiology of multiple sclerosis. , 1996, Neurologic clinics.

[40]  R. Lazzarini,et al.  A cellular mechanism governing the severity of Pelizaeus–Merzbacher disease , 1996, Nature Genetics.

[41]  G. Konat.  Chromatin structure and transcriptional activity of MAG gene. , 1996, Acta neurobiologiae experimentalis.

[42]  E. Ralston,et al.  Expression of the Adrenoleukodystrophy Protein in the Human and Mouse Central Nervous System , 1997, Neurobiology of Disease.

[43]  J L Lancaster,et al.  Magnetic resonance imaging demonstrates incomplete myelination in 18q- syndrome: evidence for myelin basic protein haploinsufficiency. , 1997, American journal of medical genetics.

[44]  A. Mackay,et al.  In vivo measurement of T2 distributions and water contents in normal human brain , 1997, Magnetic resonance in medicine.

[45]  G. Comi,et al.  Magnetization transfer ratios in multiple sclerosis lesions enhancing after different doses of gadolinium , 1998, Neurology.

[46]  J K Udupa,et al.  Correlation of volumetric magnetization transfer imaging with clinical data in MS , 1998, Neurology.

[47]  K. Nave,et al.  Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. , 1998, Science.

[48]  R. Lazzarini,et al.  Disrupted Proteolipid Protein Trafficking Results in Oligodendrocyte Apoptosis in an Animal Model of Pelizaeus-Merzbacher Disease , 1998, The Journal of cell biology.

[49]  A J Barkovich,et al.  MR of the normal neonatal brain: assessment of deep structures. , 1998, AJNR. American journal of neuroradiology.

[50]  F. Barkhof,et al.  Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis , 1998, Neurology.

[51]  M. Kiso,et al.  MyeliN‐associated Glycoprotein Binding to Gangliosides: Structural Specificity and Functional Implications a , 1998, Annals of the New York Academy of Sciences.

[52]  B. Popko,et al.  New perspectives on the function of myelin galactolipids , 1998, Trends in Neurosciences.

[53]  A. Snyder,et al.  Normal brain in human newborns: apparent diffusion coefficient and diffusion anisotropy measured by using diffusion tensor MR imaging. , 1998, Radiology.

[54]  L. Becker.  MR findings in the central nervous system of patients with a deletion of the long arm of chromosome 18(18q-) , 1998, AJNR. American journal of neuroradiology.

[55]  W. Poewe,et al.  Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. , 1999, Brain : a journal of neurology.

[56]  G. Barker,et al.  Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis , 1999, Neurology.

[57]  K. Woodward,et al.  Proteolipid protein gene: Pelizaeus-Merzbacher disease in humans and neurodegeneration in mice. , 1999, Trends in genetics : TIG.

[58]  S. Hauser,et al.  Identification of autoantibodies associated with myelin damage in multiple sclerosis , 1999, Nature Medicine.

[59]  P. Aubourg,et al.  The neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder , 1999, Trends in Neurosciences.

[60]  J. Frahm,et al.  Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. , 1999, AJNR. American journal of neuroradiology.

[61]  P. Morell,et al.  Myelin Formation, Structure and Biochemistry , 1999 .

[62]  I. Duncan,et al.  Intraventricular transplantation of oligodendrocyte progenitors into a fetal myelin mutant results in widespread formation of myelin , 1999, Annals of neurology.

[63]  Virginia M. Y. Lee,et al.  Formation of Compact Myelin Is Required for Maturation of the Axonal Cytoskeleton , 1999, The Journal of Neuroscience.

[64]  F. Barkhof,et al.  Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability , 1999, Annals of neurology.

[65]  S. Hauser,et al.  Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: A case for antigen‐specific antibody mediation , 1999, Annals of neurology.

[66]  C. Pierpaoli,et al.  Comparative MR imaging study of brain maturation in kittens with T1, T2, and the trace of the diffusion tensor. , 1999, Radiology.